Semin Neurol 2013; 33(04): 342-347
DOI: 10.1055/s-0033-1359317
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Primary Progressive Aphasia and Apraxia of Speech

Youngsin Jung
1   Departments of Neurology, Mayo Clinic, Rochester, Minnesota
,
Joseph R. Duffy
1   Departments of Neurology, Mayo Clinic, Rochester, Minnesota
,
Keith A. Josephs
1   Departments of Neurology, Mayo Clinic, Rochester, Minnesota
› Author Affiliations
Further Information

Publication History

Publication Date:
14 November 2013 (online)

Abstract

Primary progressive aphasia is a neurodegenerative syndrome characterized by progressive language dysfunction. The majority of primary progressive aphasia cases can be classified into three subtypes: nonfluent/agrammatic, semantic, and logopenic variants. Each variant presents with unique clinical features, and is associated with distinctive underlying pathology and neuroimaging findings. Unlike primary progressive aphasia, apraxia of speech is a disorder that involves inaccurate production of sounds secondary to impaired planning or programming of speech movements. Primary progressive apraxia of speech is a neurodegenerative form of apraxia of speech, and it should be distinguished from primary progressive aphasia given its discrete clinicopathological presentation. Recently, there have been substantial advances in our understanding of these speech and language disorders. The clinical, neuroimaging, and histopathological features of primary progressive aphasia and apraxia of speech are reviewed in this article. The distinctions among these disorders for accurate diagnosis are increasingly important from a prognostic and therapeutic standpoint.

 
  • References

  • 1 Pick A. Uber die beziehungen der senilen hirnatrophie zue aphasie. Prager Medicinische Wochenschrift 1892; 17: 165-167
  • 2 Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982; 11 (6) 592-598
  • 3 Gorno-Tempini ML, Hillis AE, Weintraub S , et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76 (11) 1006-1014
  • 4 Mesulam MM. Primary progressive aphasia. Ann Neurol 2001; 49 (4) 425-432
  • 5 Duffy J. Apraxia of speech in degenerative neurologic disease. Aphasiology 2006; 20: 511-527
  • 6 Ogar J, Slama H, Dronkers N, Amici S, Gorno-Tempini ML. Apraxia of speech: an overview. Neurocase 2005; 11 (6) 427-432
  • 7 Josephs KA, Duffy JR, Strand EA , et al. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain 2012; 135 (Pt 5) 1522-1536
  • 8 Grossman M, Powers J, Ash S , et al. Disruption of large-scale neural networks in non-fluent/agrammatic variant primary progressive aphasia associated with frontotemporal degeneration pathology. Brain Lang 2012; ; [Epub ahead of print]
  • 9 Grossman M. The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol 2012; 11 (6) 545-555
  • 10 Gunawardena D, Ash S, McMillan C, Avants B, Gee J, Grossman M. Why are patients with progressive nonfluent aphasia nonfluent?. Neurology 2010; 75 (7) 588-594
  • 11 Gorno-Tempini ML, Dronkers NF, Rankin KP , et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004; 55 (3) 335-346
  • 12 Ogar JM, Dronkers NF, Brambati SM, Miller BL, Gorno-Tempini ML. Progressive nonfluent aphasia and its characteristic motor speech deficits. Alzheimer Dis Assoc Disord 2007; 21 (4) S23-S30
  • 13 Josephs KA, Duffy JR, Strand EA , et al. Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology 2013; 81 (4) 337-345
  • 14 Josephs KA, Duffy JR, Strand EA , et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006; 129 (Pt 6) 1385-1398
  • 15 Josephs KA, Duffy JR, Fossett TR , et al. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants. Arch Neurol 2010; 67 (5) 596-605
  • 16 Wilson SM, Henry ML, Besbris M , et al. Connected speech production in three variants of primary progressive aphasia. Brain 2010; 133 (Pt 7) 2069-2088
  • 17 Gorno-Tempini ML, Brambati SM, Ginex V , et al. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008; 71 (16) 1227-1234
  • 18 Leyton CE, Hsieh S, Mioshi E, Hodges JR. Cognitive decline in logopenic aphasia: more than losing words. Neurology 2013; 80 (10) 897-903
  • 19 Seeley WW, Bauer AM, Miller BL , et al. The natural history of temporal variant frontotemporal dementia. Neurology 2005; 64 (8) 1384-1390
  • 20 Hodges JR, Davies RR, Xuereb JH , et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56 (3) 399-406
  • 21 Mesulam M, Wicklund A, Johnson N , et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 2008; 63 (6) 709-719
  • 22 Deramecourt V, Lebert F, Debachy B , et al. Prediction of pathology in primary progressive language and speech disorders. Neurology 2010; 74 (1) 42-49
  • 23 Kertesz A, Martinez-Lage P, Davidson W, Munoz DG. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000; 55 (9) 1368-1375
  • 24 Snowden J, Neary D, Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol 2007; 114 (1) 31-38
  • 25 Josephs KA, Stroh A, Dugger B, Dickson DW. Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol 2009; 118 (3) 349-358
  • 26 Snowden JS, Thompson JC, Stopford CL , et al. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain 2011; 134 (Pt 9) 2478-2492
  • 27 Grossman M, Xie SX, Libon DJ , et al. Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology 2008; 70 (22) 2036-2045
  • 28 Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol 2006; 59 (1) 156-165
  • 29 Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, Xuereb JH. The pathological basis of semantic dementia. Brain 2005; 128 (Pt 9) 1984-1995
  • 30 Rohrer JD, Rossor MN, Warren JD. Alzheimer's pathology in primary progressive aphasia. Neurobiol Aging 2012; 33 (4) 744-752
  • 31 Rabinovici GD, Jagust WJ, Furst AJ , et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008; 64 (4) 388-401
  • 32 Leyton CE, Villemagne VL, Savage S , et al. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging. Brain 2011; 134 (Pt 10) 3030-3043
  • 33 Lehmann M, Ghosh PM, Madison C , et al. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain 2013; 136 (Pt 3) 844-858
  • 34 Whitwell JL, Jack Jr CR, Duffy JR , et al. Microbleeds in the logopenic variant of primary progressive aphasia. Alzheimers Dement 2013; [Epub ahead of print]
  • 35 Josephs KA, Dickson DW, Murray ME , et al. Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer's disease presenting as logopenic progressive aphasia. Brain Lang 2013; [Epub ahead of print]
  • 36 Peelle JE, Troiani V, Gee J , et al. Sentence comprehension and voxel-based morphometry in progressive nonfluent aphasia, semantic dementia, and nonaphasic frontotemporal dementia. J Neurolinguist 2008; 21 (5) 418-432
  • 37 Rohrer JD, Warren JD, Modat M , et al. Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology 2009; 72 (18) 1562-1569
  • 38 Rogalski E, Cobia D, Harrison TM , et al. Anatomy of language impairments in primary progressive aphasia. J Neurosci 2011; 31 (9) 3344-3350
  • 39 Nestor PJ, Graham NL, Fryer TD, Williams GB, Patterson K, Hodges JR. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain 2003; 126 (Pt 11) 2406-2418
  • 40 Whitwell JL, Duffy JR, Strand EA , et al. Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: an MRI and FDG-PET study. Brain Lang 2013; 125 (3) 245-252
  • 41 Shewan CM, Kertesz A. Reliability and validity characteristics of the Western Aphasia Battery (WAB). J Speech Hear Disord 1980; 45 (3) 308-324
  • 42 De Renzi E, Vignolo LA. The token test: A sensitive test to detect receptive disturbances in aphasics. Brain 1962; 85: 665-678
  • 43 Mummery CJ, Patterson K, Price CJ, Ashburner J, Frackowiak RS, Hodges JR. A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol 2000; 47 (1) 36-45
  • 44 Madhavan A, Whitwell JL, Weigand SD , et al. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type. PLoS ONE 2013; 8 (4) e62471
  • 45 Rohrer JD, Clarkson MJ, Kittus R , et al. Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration. J Alzheimers Dis 2012; 30 (2) 407-411
  • 46 Josephs KA, Whitwell JL, Duffy JR , et al. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology 2008; 70 (1) 25-34
  • 47 Rogalski E, Cobia D, Harrison TM, Wieneke C, Weintraub S, Mesulam MM. Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia. Neurology 2011; 76 (21) 1804-1810
  • 48 Goldman JS, Farmer JM, Wood EM , et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 2005; 65 (11) 1817-1819
  • 49 van Swieten J, Spillantini MG. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 2007; 17 (1) 63-73
  • 50 Mesulam M, Johnson N, Krefft TA , et al. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol 2007; 64 (1) 43-47
  • 51 Josephs KA, Ahmed Z, Katsuse O , et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 2007; 66 (2) 142-151
  • 52 Snowden JS, Rollinson S, Thompson JC , et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012; 135 (Pt 3) 693-708
  • 53 Mahoney CJ, Beck J, Rohrer JD , et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012; 135 (Pt 3) 736-750
  • 54 van der Zee J, Rademakers R, Engelborghs S , et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain 2006; 129 (Pt 4) 841-852
  • 55 Duffy JR, McNeil MR. Primary progressive aphasia and apraxia of speech. In: Chapey R, , ed. Language Intervention Strategies in Aphasia and Related Neurogenic Communication Disorders. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007: 543-564
  • 56 Beeson PM, King RM, Bonakdarpour B, Henry ML, Cho H, Rapcsak SZ. Positive effects of language treatment for the logopenic variant of primary progressive aphasia. J Mol Neurosci 2011; 45 (3) 724-736
  • 57 Henry ML, Meese MV, Truong S, Babiak MC, Miller BL, Gorno-Tempini ML. Treatment for apraxia of speech in nonfluent variant primary progressive aphasia. Behav Neurol 2013; 26 (1-2) 77-88
  • 58 Pattee C, Von Berg S, Ghezzi P. Effects of alternative communication on the communicative effectiveness of an individual with a progressive language disorder. Int J Rehabil Res 2006; 29 (2) 151-153